Patients with clotting disorders, including hemophilias A and B, and von Willebrand Disease generally receive pooled human blood products, and are at high risk for HIV-1 and hepatitis A, B and C viral infection. This retrospective study describes patients receiving treatment at a federally funded Hemophilia Treatment Center (HTC) from 1998 - 2002 and assesses the prevalence of viral infection. In addition, current rates of viral infection are compared to 1984-1996 rates.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
viral infection
12
prevalence viral
8
viral hepatitis
4
hepatitis hiv
4
hiv infections
4
infections patients
4
patients congenital
4
congenital bleeding
4
bleeding disorders
4
disorders patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!